The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $20,439,540 in first-year total cost, median $2,452,224.
Most frequent study sections
- Special Emphasis Panel[ZHL1 PPG-S (M1)]7
- Special Emphasis Panel[ZHL1 PPG-S (F1)]2
Most frequent institutions
- CASE WESTERN RESERVE UNIVERSITY1
- CLEVELAND CLINIC LERNER COM-CWRU1
- STANFORD UNIVERSITY1
- UNIV OF MASSACHUSETTS MED SCH WORCESTER1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease2P01HL114470-06 | THANNICKAL, VICTOR J. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $1,671,476 | ZHL1 |
| 2017 | Development of Novel Mycolytic Therapies for Lung Disease2P01HL108808-06 | BOUCHER, RICHARD CHARLESPEDEN, DAVID B. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,452,224 | ZHL1 |
| 2017 | Elafin Therapy for Pulmonary Arterial Hypertension2P01HL108797-06 | RABINOVITCH, MARLENE | STANFORD UNIVERSITY, CA | $1,790,971 | ZHL1 |
| 2017 | Hormonal, Metabolic and Signaling Interactions in PAH2P01HL108800-07 | HEMNES, ANNA RLOYD, JAMES E | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $1,705,535 | ZHL1 |
| 2016 | Therapeutic Targeting of Vascular Subphenotypes of Lung Disease2P01HL103455-06 | GLADWIN, MARK T | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,704,375 | ZHL1 |
| 2016 | Asthma Inflammation Research2P01HL103453-06 | ERZURUM, SERPIL C. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $2,667,320 | ZHL1 |
| 2016 | Personalized small molecule therapy for severe asthma and cystic fibrosis.1P01HL128192-01A1 | GASTON, BENJAMIN | CASE WESTERN RESERVE UNIVERSITY, OH | $2,660,551 | ZHL1 |
| 2016 | Carbohydrate-based Therapy for Lung Disease1P01HL128191-01A1 | FAHY, JOHN V | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,534,255 | ZHL1 |
| 2016 | New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency1P01HL131471-01 | FLOTTE, TERENCE R. | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $2,252,833 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.